Patent: 4,195,127
✉ Email this page to a colleague
Summary for Patent: 4,195,127
Title: | Process for immobilizing proteins |
Abstract: | A protein which can be an enzyme is immobilized by: (a) admixing the protein and an isocyanate-capped liquid polyurethane prepolymer to form an intermediate product; and (b) foaming the intermediate product by reacting it with water to form a polyurethane foam comprising the immobilized enzyme. |
Inventor(s): | Hartdegen; Frank J. (Columbia, MD), Swann; Wayne E. (Pasadena, MD) |
Assignee: | W. R. Grace & Co. (New York, NY) |
Application Number: | 05/851,932 |
Patent Claims: | see list of patent claims |
Details for Patent 4,195,127
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 1996-02-24 |
Csl Behring Ag | CARIMUNE, CARIMUNE NF, PANGLOBULIN, SANDOGLOBULIN | immune globulin intravenous (human) | For Injection | 102367 | 07/27/2000 | ⤷ Try a Trial | 1996-02-24 |
Csl Behring Ag | PRIVIGEN | immune globulin intravenous (human), 10% liquid | Injection | 125201 | 07/26/2007 | ⤷ Try a Trial | 1996-02-24 |
Csl Behring Ag | PRIVIGEN | immune globulin intravenous (human), 10% liquid | Injection | 125201 | 10/02/2009 | ⤷ Try a Trial | 1996-02-24 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |